SEEKIN
SeekIn is focusing on blood-based pan cancer early diagnosis with a mission to reduce cancer mortality by 10% in the screened population by 2030.Cancer early detection is probably the most cost-effective means to reduce cancer mortality as prognosis is much better when cancer is detected and treated at the early stage.
SEEKIN
Social Links:
Industry:
Biotechnology Health Care
Founded:
2018-01-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.en.seekincancer.com
Total Employee:
11+
Status:
Active
Contact:
400-686-8501
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Content Delivery Network Google Universal Analytics Euro Pound Sterling OpenResty Japanese Yen Alibaba
Current Employees Featured
Founder
Investors List
Green Pine Capital Partners
Green Pine Capital Partners investment in Angel Round - SeekIn
Shenzhenshi IECSZ Fund Investment Management
Shenzhenshi IECSZ Fund Investment Management investment in Angel Round - SeekIn
Official Site Inspections
http://www.en.seekincancer.com
Unable to get host informations!!!
More informations about "SeekIn"
SeekIn
The management team of SeekIn consists of experts with insightful and complementary experiences in R&D, clinical lab management, business operations, corporate finance, and …See details»
SeekIn - Crunchbase Company Profile & Funding
SeekIn is focusing on blood-based pan cancer early diagnosis with a mission to reduce cancer mortality.See details»
Ground-breaking new technology for multi-cancer …
Dec 11, 2023 For more information about SeekIn’s cutting-edge technologies and products, visit www.seekincancer.com. SeekIn lt is a fully-owned US-based entity of SeekIn. About Inspire2Live Inspire2Live is an patient advocacy …See details»
SeekIn and OncoInv Collaborate to Expand the Global Accessibility …
Dec 15, 2023 SeekIn to Grant Oncolnv the Rights to Represent SeekIn's Comprehensive Range of Cancer Detection Tests in Twelve Countries to Provide Individuals with Accessible and …See details»
SeekIn’s OncoSeek advances cancer detection - Medical Device …
Jun 19, 2023 The OncoSeek technology by SeekIn will head early cancer detection in low-income and middle-income countries.See details»
Mao Mao - Inspire2Live
As one of the founding members of the National Human Genome Center in Shanghai, he established the first high-throughput DNA sequencing facility and pioneered genome research in China. He published 100+ articles in the peer …See details»
SeekIn paves the way for cancer early detection in low- and middle ...
Jun 16, 2023 OncoSeek® is a revolutionary multi-cancer early detection (MCED) test developed by SeekIn and empowered by AI technology to significantly reduce the false...See details»
SeekIn Presents New Data Supporting its Pan-cancer Early …
Oct 19, 2022 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, today announced the results of pan-cancer early detection...See details»
SeekIn CEO's Vision: Bridging Gaps for Equitable Health...
Dr. Mao Mao, CEO of SeekIn and a globally recognized scientist, was an invited speaker at a symposium hosted by Inspire2Live at the Royal Netherlands Academy of Arts and Sciences. …See details»
Technology - SeekIn
We use the combination of sWGS and PTMs to search for common cancer features in blood for pan-cancer early detection.See details»
SeekIn Secures Five U.S. Trademarks for Breakthrough Ca...
With these newly secured U.S. trademarks, SeekIn is poised to expand its presence and enhance its service offerings in the American market, while leveraging established approvals in China …See details»
SeekInCare - SeekIn
When cancer is detected at the early stage, treatment is more effective and survival drastically improves. Yet ~50% of cancers are still only detected at an advanced stage. SeekInCare ® is …See details»
Shujia Hao - Inspire2Live
My name is Shujia Hao, and I bring nearly 20 years of experience in financial management, with 15 of those years focused in the healthcare industry. I am currently the co-founder of SeekIn …See details»
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer …
Feb 24, 2022 SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) Mark for SeekInCare® Cancer …See details»
The Skin Cancer Foundation - Official Website
The Skin Cancer Foundation saves and improves lives. We empower people to take a proactive approach to daily sun protection and the early detection and treatment of skin cancer.See details»
Oncoinv - SeekIn & OncoInv join forces
Dec 1, 2023 For more information about SeekIn’s cutting-edge technologies and products, visit www.seekincancer.com. About Inspire2Live Inspire2Live is an international patient advocacy …See details»
OncoSeek - SeekIn
OncoSeek® is a machine learning algorithm that uses the results of a simple blood test to detect 9 high mortality cancer types by analyzing the concentration of a panel of protein tumour …See details»
SeekInCare Blood Test Can Detect More Than 20 Cancer Types
Aug 7, 2023 SeekInCare, a blood-based multi-cancer detection test, can detect more than 20 cancer types with high specificity, according to researchers.See details»
Canadian Cancer Society
As Canada’s largest national cancer charity, the Canadian Cancer Society funds cancer research, offers cancer support services and shares trusted information.See details»
SeekIn Receives CE Mark Approval for SeekInCare® Pan Cancer …
SHENZHEN, China, Feb. 24, 2022 /PRNewswire/ -- SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, today announced the CE (Conformité Européenne) …See details»